Epidermolysis Bullosa Simplex

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

InMed Pharmaceuticals
InMed PharmaceuticalsVANCOUVER, British Columbia, Canada
1 program
1
INM-755Phase 21 trial
Active Trials
NCT04908215CompletedEst. Apr 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
InMed PharmaceuticalsINM-755

Clinical Trials (1)

NCT04908215InMed PharmaceuticalsINM-755

INM-755 (Cannabinol) Cream for Treatment of Epidermolysis Bullosa

Start: Dec 2021Est. completion: Apr 2023
Phase 2Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space